• Explore /
  • Poster
  • / CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial.

CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial.

Abstract Poster

Authors

null

Gregory P. Botta

University of California, San Diego Moores Cancer Center, La Jolla, CA

Gregory P. Botta , Ronan Joseph Kelly , Zhaohui Jin , Hong Ma , Geoffrey Yuyat Ku , Dan Zhao , Rutika Mehta , Julia C. Carnevale , Gloria Sierra , JIE JIA , Raffaele Baffa , Zhonghai Li , Dae Won Kim , Harry H. Yoon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04404595

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 356)

DOI

10.1200/JCO.2024.42.3_suppl.356

Abstract #

356

Poster Bd #

G17

Abstract Disclosures

Similar Posters

First Author: Gregory P. Botta

First Author: Armin Ghobadi

First Author: David Bing Zhen

First Author: Na Zhang